神経因性膀胱に対するロバベロンの治療効果 -標準薬臭化ジスチグミンならびにプラセボーとの二重盲検法による比較-

概要

論文の詳細を見る
Therapeutic effect of Robaveron was evaluated by means of the double blind method with Distigmine Bromide as a standard drug and a placebo. The drugs were administered in a double dummy fashion. The Robaveron group showed the best result compared with the Distigmine Bromide or placebo group in decrease of residual urine, improvement of practical residual urine rate, and the over-all voiding efficiency. Robaveron was also proved to be excellent in the over-all improvement, usefullness and safty. Through this study pathophysiology of neurogenic bladder dysfunction to which Robaveron is indicated was cleared.